Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity

• Ruth J. Napier ,

  Contributed equally to this work with: Ruth J. Napier, Brian A. Norris

  Affiliation Microbiology and Molecular Genetics Graduate Program, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Brian A. Norris ,

  Contributed equally to this work with: Ruth J. Napier, Brian A. Norris

  Affiliation Immunology and Molecular Pathogenesis Graduate Program, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Alyson Swimm,

  Affiliation Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Cynthia R. Giver,

  Affiliation Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Wayne A. C. Harris,

  Affiliation Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Julie Laval,

  Affiliations Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America, Center for Cystic Fibrosis Research, Children’s Healthcare of Atlanta, Atlanta, Georgia, United States of America, Institut de Génétique Moléculaire de Montpellier (IGMM), CNRS UMR5535, Université Montpellier, Montpellier, France

  ⨯
• Brooke A. Napier,

  Affiliation Microbiology and Molecular Genetics Graduate Program, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Gopi Patel,

  Affiliation Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Ryan Crump,

  Affiliation Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, Missouri, United States of America

  ⨯
• Zhenghong Peng,

  Affiliation MD Anderson Cancer Center, University of Texas, Houston, Texas, United States of America

  ⨯
• William Bornmann,

  Affiliation MD Anderson Cancer Center, University of Texas, Houston, Texas, United States of America

  ⨯
• Bali Pulendran,

  Affiliations Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America, Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America

  ⨯
• R. Mark Buller,

  Affiliation Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, Missouri, United States of America

  ⨯
• David S. Weiss,

  Affiliations Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Rabindra Tirouvanziam,

  Affiliations Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America, Center for Cystic Fibrosis Research, Children’s Healthcare of Atlanta, Atlanta, Georgia, United States of America

  ⨯
• Edmund K. Waller,

  Affiliation Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America

  ⨯
•  [ ... ],
• Daniel Kalman

  * E-mail: dkalman@emory.edu

  Affiliation Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• [ view all ]
• [ view less ]